Annual Cash & Cash Equivalents
$568.50 M
-$768.38 M-57.48%
December 31, 2023
Summary
- As of February 7, 2025, NVAX annual cash & cash equivalents is $568.50 million, with the most recent change of -$768.38 million (-57.48%) on December 31, 2023.
- During the last 3 years, NVAX annual cash & cash equivalents has risen by +$15.11 million (+2.73%).
- NVAX annual cash & cash equivalents is now -62.48% below its all-time high of $1.52 billion, reached on December 31, 2021.
Performance
NVAX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$573.63 M
-$106.53 M-15.66%
September 30, 2024
Summary
- As of February 7, 2025, NVAX quarterly cash and cash equivalents is $573.63 million, with the most recent change of -$106.53 million (-15.66%) on September 30, 2024.
- Over the past year, NVAX quarterly cash and cash equivalents has dropped by -$77.47 million (-11.90%).
- NVAX quarterly cash and cash equivalents is now -72.35% below its all-time high of $2.07 billion, reached on June 30, 2021.
Performance
NVAX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NVAX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.5% | -11.9% |
| 3 y3 years | +2.7% | -62.1% |
| 5 y5 years | +710.4% | +218.9% |
NVAX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.5% | at low | -63.5% | +19.4% |
| 5 y | 5-year | -62.5% | +621.2% | -72.3% | +627.7% |
| alltime | all time | -62.5% | >+9999.0% | -72.3% | >+9999.0% |
Novavax Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $573.63 M(-15.7%) |
| Jun 2024 | - | $680.16 M(+41.5%) |
| Mar 2024 | - | $480.59 M(-15.5%) |
| Dec 2023 | $568.50 M(-57.5%) | $568.50 M(-12.7%) |
| Sep 2023 | - | $651.10 M(+28.7%) |
| Jun 2023 | - | $505.91 M(-19.0%) |
| Mar 2023 | - | $624.95 M(-53.3%) |
| Dec 2022 | $1.34 B(-11.8%) | $1.34 B(+4.4%) |
| Sep 2022 | - | $1.28 B(-6.9%) |
| Jun 2022 | - | $1.38 B(-12.4%) |
| Mar 2022 | - | $1.57 B(+3.7%) |
| Dec 2021 | $1.52 B(+173.8%) | $1.52 B(-21.8%) |
| Sep 2021 | - | $1.94 B(-6.6%) |
| Jun 2021 | - | $2.07 B(+4.0%) |
| Mar 2021 | - | $2.00 B(+260.6%) |
| Dec 2020 | $553.40 M(+602.1%) | $553.40 M(+65.6%) |
| Sep 2020 | - | $334.17 M(-21.3%) |
| Jun 2020 | - | $424.39 M(+135.9%) |
| Mar 2020 | - | $179.88 M(+128.2%) |
| Dec 2019 | $78.82 M(+12.4%) | $78.82 M(+10.8%) |
| Sep 2019 | - | $71.17 M(-1.2%) |
| Jun 2019 | - | $72.00 M(-26.3%) |
| Mar 2019 | - | $97.71 M(+39.3%) |
| Dec 2018 | $70.15 M(-34.0%) | $70.15 M(+24.2%) |
| Sep 2018 | - | $56.50 M(-36.1%) |
| Jun 2018 | - | $88.47 M(-22.0%) |
| Mar 2018 | - | $113.40 M(+6.7%) |
| Dec 2017 | $106.31 M(-26.4%) | $106.31 M(+2.0%) |
| Sep 2017 | - | $104.25 M(+37.5%) |
| Jun 2017 | - | $75.79 M(-20.9%) |
| Mar 2017 | - | $95.85 M(-33.6%) |
| Dec 2016 | $144.35 M(+55.0%) | $144.35 M(+20.3%) |
| Sep 2016 | - | $119.95 M(+34.2%) |
| Jun 2016 | - | $89.39 M(-32.4%) |
| Mar 2016 | - | $132.22 M(+42.0%) |
| Dec 2015 | $93.11 M(+187.9%) | $93.11 M(-32.6%) |
| Sep 2015 | - | $138.14 M(-17.5%) |
| Jun 2015 | - | $167.38 M(-22.2%) |
| Mar 2015 | - | $215.05 M(+565.1%) |
| Dec 2014 | $32.34 M(-72.9%) | $32.34 M(-6.2%) |
| Sep 2014 | - | $34.47 M(-66.8%) |
| Jun 2014 | - | $103.86 M(-5.5%) |
| Mar 2014 | - | $109.92 M(-8.0%) |
| Dec 2013 | $119.47 M(+586.7%) | $119.47 M(-2.5%) |
| Sep 2013 | - | $122.49 M(+4658.9%) |
| Jun 2013 | - | $2.57 M(-71.5%) |
| Mar 2013 | - | $9.02 M(-48.1%) |
| Dec 2012 | $17.40 M(+23.4%) | $17.40 M(+62.0%) |
| Sep 2012 | - | $10.74 M(-30.0%) |
| Jun 2012 | - | $15.33 M(+10.5%) |
| Mar 2012 | - | $13.87 M(-1.6%) |
| Dec 2011 | $14.10 M(+75.0%) | $14.10 M(-1.5%) |
| Sep 2011 | - | $14.32 M(+9.4%) |
| Jun 2011 | - | $13.09 M(+56.6%) |
| Mar 2011 | - | $8.36 M(+3.7%) |
| Dec 2010 | $8.06 M | $8.06 M(-50.3%) |
| Sep 2010 | - | $16.21 M(+71.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $9.45 M(-35.2%) |
| Mar 2010 | - | $14.57 M(-62.4%) |
| Dec 2009 | $38.76 M(+43.9%) | $38.76 M(+29.3%) |
| Sep 2009 | - | $29.98 M(+18.9%) |
| Jun 2009 | - | $25.22 M(+28.5%) |
| Mar 2009 | - | $19.63 M(-27.1%) |
| Dec 2008 | $26.94 M(+519.3%) | $26.94 M(-26.8%) |
| Sep 2008 | - | $36.79 M(+56.5%) |
| Jun 2008 | - | $23.51 M(+59.9%) |
| Mar 2008 | - | $14.70 M(+238.0%) |
| Dec 2007 | $4.35 M(-39.3%) | $4.35 M(-72.5%) |
| Sep 2007 | - | $15.82 M(+115.6%) |
| Jun 2007 | - | $7.34 M(-5.7%) |
| Mar 2007 | - | $7.78 M(+8.7%) |
| Dec 2006 | $7.16 M(-77.5%) | $7.16 M(-66.4%) |
| Sep 2006 | - | $21.29 M(-72.9%) |
| Jun 2006 | - | $78.60 M(-6.4%) |
| Mar 2006 | - | $83.94 M(+163.2%) |
| Dec 2005 | $31.89 M(+78.4%) | $31.89 M(+359.3%) |
| Sep 2005 | - | $6.94 M(+56.3%) |
| Jun 2005 | - | $4.44 M(-51.7%) |
| Mar 2005 | - | $9.20 M(-48.5%) |
| Dec 2004 | $17.88 M(-35.3%) | $17.88 M(-35.0%) |
| Sep 2004 | - | $27.50 M(+76.0%) |
| Jun 2004 | - | $15.62 M(-28.6%) |
| Mar 2004 | - | $21.89 M(-20.8%) |
| Dec 2003 | $27.63 M(+819.6%) | $27.63 M(+357.1%) |
| Sep 2003 | - | $6.04 M(-37.2%) |
| Jun 2003 | - | $9.63 M(-32.8%) |
| Mar 2003 | - | $14.32 M(+376.5%) |
| Dec 2002 | $3.00 M(-85.0%) | $3.00 M(-60.6%) |
| Sep 2002 | - | $7.63 M(-52.1%) |
| Jun 2002 | - | $15.93 M(+46.3%) |
| Mar 2002 | - | $10.88 M(-45.7%) |
| Dec 2001 | $20.05 M(+34.9%) | $20.05 M(-14.0%) |
| Sep 2001 | - | $23.30 M(+103.7%) |
| Jun 2001 | - | $11.44 M(+28.6%) |
| Mar 2001 | - | $8.89 M(-40.2%) |
| Dec 2000 | $14.86 M(+2023.4%) | $14.86 M(+47.8%) |
| Sep 2000 | - | $10.06 M(-18.1%) |
| Jun 2000 | - | $12.29 M(-16.4%) |
| Mar 2000 | - | $14.69 M(+1999.0%) |
| Dec 1999 | $700.00 K(-30.0%) | $700.00 K(-30.0%) |
| Sep 1999 | - | $1.00 M(-64.3%) |
| Jun 1999 | - | $2.80 M(+833.3%) |
| Mar 1999 | - | $300.00 K(-70.0%) |
| Dec 1998 | $1.00 M(-73.7%) | $1.00 M(-86.1%) |
| Sep 1998 | - | $7.20 M(-13.3%) |
| Jun 1998 | - | $8.30 M(-9.8%) |
| Mar 1998 | - | $9.20 M(+142.1%) |
| Dec 1997 | $3.80 M(+52.0%) | $3.80 M(-20.8%) |
| Sep 1997 | - | $4.80 M(-17.2%) |
| Jun 1997 | - | $5.80 M(-14.7%) |
| Mar 1997 | - | $6.80 M(+172.0%) |
| Dec 1996 | $2.50 M | $2.50 M(+19.0%) |
| Sep 1996 | - | $2.10 M(-30.0%) |
| Jun 1996 | - | $3.00 M(-23.1%) |
| Mar 1996 | - | $3.90 M |
FAQ
- What is Novavax annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Novavax?
- What is Novavax annual cash & cash equivalents year-on-year change?
- What is Novavax quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Novavax?
- What is Novavax quarterly cash and cash equivalents year-on-year change?
What is Novavax annual cash & cash equivalents?
The current annual cash & cash equivalents of NVAX is $568.50 M
What is the all time high annual cash & cash equivalents for Novavax?
Novavax all-time high annual cash & cash equivalents is $1.52 B
What is Novavax annual cash & cash equivalents year-on-year change?
Over the past year, NVAX annual cash & cash equivalents has changed by -$768.38 M (-57.48%)
What is Novavax quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NVAX is $573.63 M
What is the all time high quarterly cash and cash equivalents for Novavax?
Novavax all-time high quarterly cash and cash equivalents is $2.07 B
What is Novavax quarterly cash and cash equivalents year-on-year change?
Over the past year, NVAX quarterly cash and cash equivalents has changed by -$77.47 M (-11.90%)